Proclin Pharma — pharmaceutical regulatory labeling
Redesign of the pharmaceutical labeling system under INVIMA requirements — from the editorial template to the approval flow, focused on traceability, clinical legibility, and response times for industrial batches.
Compliance without sacrificing speed.
The previous system accumulated observations at every batch review: typographic inconsistencies, confusing warning hierarchy, long internal approval times.
The brief: a redesign that would pass INVIMA audits without observations and that the team could sustain at industrial pace, batch after batch, without reopening every artwork.
Editorial templates, not loose artworks.
We built a master template with the regulatory hierarchy embedded — mandatory fields, safety margins, typographic zones, and coded warnings.
We defined a step-by-step documented approval flow with archivable evidence for each batch. Design went from deliverable to auditable process.
Labels produced per month, zero observations.
Monthly batches sustained with INVIMA approval and no rework. Auditable, documented, scalable to real production volume.